Showing posts with label Furosemide. Show all posts
Showing posts with label Furosemide. Show all posts

Friday, 20 May 2022

Visible Quantitative Methods for the Determination of Furosemide in Pure form and Pharmaceutical Formulations: A Recent Study| Chapter 10 | Progress in Chemical Science Research Vol. 1

The goal of this research is to develop technological methods for determining furosemide in both its pure and pharmaceutical dose forms utilising spectral approaches.

This study was designed and carried out to assess Furosemide in pure and pharmaceutical dose forms using visible spectrophotometry.

This research was conducted from April to August 2021 at the Laboratory of Analytical Research, chemistry department, college of Science, University of Mosul, Mosul, Iraq.

The drug Lazix is made up of furosemide, which is used to treat heart disease and high blood pressure. To record the pH data, the researchers used a JASCO V – 630 double-beam computerised UV-Visible spectrophotometer with a 1 cm matched cell and a HANA pH metre.

Furosemide interacts with bromo-phenol blue, xylenol orange, and chromazorol S, according to research. The decreasing intensity of the resulting coloured complex was measured using bromo-phenol blue and xylenol orange, whereas the rising colour intensity was measured using method (C). The charge transfer reaction was used in all three approaches. The limits of Beer's law were 0.8-32 g. mL-1 for method (A), 1-32 g. mL-1 for method (B), and 1-32 g. mL-1 for method (C), depending on the level of concentration, while the molar absorption coefficients were 1.4104, 2.1104, and 1.57104 l.mol-1.cm-1 for the first, second, and third methods, respectively. For these three approaches, Sandel's significance was estimated as follows: 0.0157 g.cm-2 for the first method, 0.0236 g.cm-2 for the second method, and 0.0236 g.cm-2 for the third way. 0.0210 g.cm-2 was used in the third approach. With considerable success, the method has been used to identify furosemide in both its pure form and certain pharmaceutical forms.

The suggested methodologies were validated in terms of linearity, range, accuracy, precision, specificity, and robustness. Method (B) was determined to be the best method based on the best values of molar absorptivity, stability of the resulting complex, and method (A) was determined to be the best method based on the best values of molar absorptivity, stability of the resulting complex, and method (A) was determined to be the best method (B).

Author(s) Details:

Basima A. A. Saleem,
Department of Chemistry, College of Science, University of Mosul, Mosul, Iraq.

Enaam A. Hamdon,
Department of Chemistry, College of Science, University of Mosul, Mosul, Iraq.

Sahbaa Y. Majeed,
Department of Chemistry, College of Science, University of Mosul, Mosul, Iraq.

Please see the link here: https://stm.bookpi.org/PCSR-V1/article/view/6768

Sunday, 23 January 2022

Screening of Anti Diuretic Activity Aerva Lanata Extracts against Furosemide Exposed Rodent Models | Chapter 16 | New Visions in Biological Science Vol. 8

 Bioactive chemicals from aromatic and medicinal plants demonstrated excellent antibacterial and antifungal activity. The antidiuretic activity of the Aerva lanata was researched and described in the current study. Medicinal plants were utilised to inhibit infections and cure most disorders such as diuretics and diabetics. Total urine production in normal animas was 1.320.22 ml/kg per day in this study, but diuretic animals had 1.76 0.26 ml/kg per day. In this study, it was enhanced by 44% and the diuretic activity was stimulated 1.5 times. The percentage secretion of saline caused by furosemide (a common diuretic medication) was 8.520.56 and urine excretion was 7.380.53. The active ingredient in Aerva lanata was shown to lower the significant and return to the control value, as well as to have antidiuretic properties. Total urine output was 1.30 0.27 ml/kg of animal per day in diuretic-induced animals treated with 2-Decyl -1-tetra decanol compared to control (1.320.22 ml/kg of animal per day), a drop of 2% and a one-fold stimulation of diuretic action. 2-Decyl -1-tetra decanol, the active component of A. Lanata, generated a percentage of saline secretion of 8.760.52 and urine excretion of 7.490.48. The active components of Aerva lanata were shown to have a similar value to the conventional antidiuretic hormone. According to research, Aerva lanata can be utilised as an effective, low-cost plant-based medication for diuretic disorders.


Author(S) Details

N. Shyam Sundar
Department of Zoology, Sri Paramakalyani College, Alwarkurichi-627 412, India.

P. Dhasarathan
Department of Biotechnology, Prathyusha Engineering College, Chennai-602025, India.

K. R. Narayanan
Department of Zoology, Sri Paramakalyani College, Alwarkurichi-627 412, India.

M. Thenmozhi

Department of Biotechnology, Prathyusha Engineering College, Chennai-602025, India.

View Book:- https://stm.bookpi.org/NVBS-V8/article/view/5401

Tuesday, 27 July 2021

A Comparative Analysis of Dissolution Profiles of Furosemide Tablets Available in the Argentinean Market (Part 2) | Chapter 9 | Current Advances in Chemistry and Biochemistry Vol. 9

 The qualities of the active pharmaceutical ingredient (API) as well as the features of the dosage form influence the rate and degree of medication dissolution and absorption. The dissolving patterns of furosemide tablets from nine commercially available products in Argentina were investigated in this study. All of the brands meet the USP dissolution test requirements. Model-dependent and model-independent techniques were used to compare dissolution profiles. The optimum kinetic curve adjustment came from the Weibull model. The most fitting brands were IV, VI, and IX, which had the highest determination coefficient and the least AIC values. The results of the model-independent approach revealed that there was no significant difference in Dissolution efficiency or Mean dissolution time between the reference product and Brands II, III, IV, and V. Only Brands I and III were equivalent in terms of fit factors. In vivo bioequivalence of furosemide market goods has been proven, and interchangeability with generics should be avoided.


Author (s) Details

Yong K. Han
Cátedra de Calidad de Medicamentos, Facultad de Farmacia y Bioquímica. Universidad de Buenos Aires, CONICET, Junín 956 (1113) CABA, Argentina.

Laura D. Simionato
Cátedra de Calidad de Medicamentos, Facultad de Farmacia y Bioquímica. Universidad de Buenos Aires, CONICET, Junín 956 (1113) CABA, Argentina.

Romina G. Calvo
Cátedra de Calidad de Medicamentos, Facultad de Farmacia y Bioquímica. Universidad de Buenos Aires, CONICET, Junín 956 (1113) CABA, Argentina.

María B. Mattei
Cátedra de Calidad de Medicamentos, Facultad de Farmacia y Bioquímica. Universidad de Buenos Aires, CONICET, Junín 956 (1113) CABA, Argentina.

Adriana I. Segall
Cátedra de Calidad de Medicamentos, Facultad de Farmacia y Bioquímica. Universidad de Buenos Aires, CONICET, Junín 956 (1113) CABA, Argentina.

View Book :- https://stm.bookpi.org/CACB-V9/article/view/2200